0\" encoding=\"UTF-8\"?>\n<table frame=\"hsides\" rules=\"groups\"><thead><tr><th rowspan=\"1\" colspan=\"1\"/><th align=\"left\" rowspan=\"1\" colspan=\"1\">Natalizumab + IFNbeta-1a(n = 589)</th><th align=\"left\" rowspan=\"1\" colspan=\"1\">Placebo + IFNbeta-1a(n = 582)</th><th align=\"left\" rowspan=\"1\" colspan=\"1\">P-Value</th></tr></thead><tbody><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\"><bold>SENTINEL <xref ref-type=\"bibr\" rid=\"b38\">Rudick, Stuart, et al 2006</xref></bold></td><td rowspan=\"1\" colspan=\"1\"/><td rowspan=\"1\" colspan=\"1\"/><td rowspan=\"1\" colspan=\"1\"/></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">Clinical endpoints</td><td rowspan=\"1\" colspan=\"1\"/><td rowspan=\"1\" colspan=\"1\"/><td rowspan=\"1\" colspan=\"1\"/></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">Annualized relapse rate, mean (95% CI)</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">0.34 (0.29, 0.39)</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">0.75 (0.67, 0.84)</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">&lt;0.001</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">Sustained disability progression, % of patients</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">23</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">29</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">0.02</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">MRI endpoints (lesions per patient)</td><td rowspan=\"1\" colspan=\"1\"/><td rowspan=\"1\" colspan=\"1\"/><td rowspan=\"1\" colspan=\"1\"/></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">No. of new or enlarging T2 lesions, mean +- SD</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">0.9 +- 2.1</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">5.4 +- 8.7</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">&lt;0.001</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">No. of Gd<sup>+</sup> lesions, mean +- SD</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">0.1 +- 0.6</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">0.9 +- 3.2</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">&lt;0.001</td></tr></tbody></table>\n"}, "text": "\tNatalizumab (n = 627)\tPlacebo (n = 315)\tP-Value\t \tAFFIRM \t\t\t\t \tClinical endpoints\t\t\t\t \tAnnualized relapse rate, mean (95% CI)\t0.23 (0.19, 0.28)\t0.73 (0.62, 0.87)\t<0.001\t \tSustained disability progressiona, % of patients\t17\t29\t<0.001\t \tMRI endpoints (lesions per patient)\t\t\t\t \tNo. of new or enlarging T2 lesions, mean +- SD\t1.9 +- 9.2\t11.0 +- 15.7\t<0.001\t \tNo. of Gd+ lesions, mean +- SD\t0.1 +- 1.4\t1.2 +- 3.9\t<0.001\t \t", "sentences": [], "annotations": [], "relations": []}, {"offset": 22445, "infons": {"file": "tbl3.xml", "id": "tbl3", "section_type": "TABLE", "type": "table", "xml": "<?xml version=\"1.0\" encoding=\"UTF-8\"?>\n<table frame=\"hsides\" rules=\"groups\"><thead><tr><th rowspan=\"1\" colspan=\"1\"/><th align=\"left\" rowspan=\"1\" colspan=\"1\">Natalizumab + IFNbeta-1a(n = 589)</th><th align=\"left\" rowspan=\"1\" colspan=\"1\">Placebo + IFNbeta-1a(n = 582)</th><th align=\"left\" rowspan=\"1\" colspan=\"1\">P-Value</th></tr></thead><tbody><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\"><bold>SENTINEL <xref ref-type=\"bibr\" rid=\"b38\">Rudick, Stuart, et al 2006</xref></bold></td><td rowspan=\"1\" colspan=\"1\"/><td rowspan=\"1\" colspan=\"1\"/><td rowspan=\"1\" colspan=\"1\"/></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">Clinical endpoints</td><td rowspan=\"1\" colspan=\"1\"/><td rowspan=\"1\" colspan=\"1\"/><td rowspan=\"1\" colspan=\"1\"/></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">Annualized relapse rate, mean (95% CI)</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">0.34 (0.29, 0.39)</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">0.75 (0.67, 0.84)</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">&lt;0.001</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">Sustained disability progression, % of patients</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">23</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">29</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">0.02</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">MRI endpoints (lesions per patient)</td><td rowspan=\"1\" colspan=\"1\"/><td rowspan=\"1\" colspan=\"1\"/><td rowspan=\"1\" colspan=\"1\"/></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">No. of new or enlarging T2 lesions, mean +- SD</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">0.9 +- 2.1</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">5.4 +- 8.7</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">&lt;0.001</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">No. of Gd<sup>+</sup> lesions, mean +- SD</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">0.1 +- 0.6</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">0.9 +- 3.